Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : 3M-052,Potassium Alum
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Preclinical
Sponsor : IDRI
Deal Size : Undisclosed
Deal Type : Collaboration
Details : Vaccine candidate, which combines a nanoparticle developed by a Duke-led research team with IDRI’s novel formulation of 3M’s “3M-052” compound Produced more “broadly neutralizing antibodies” against several strains of coronavirus, including b...
Product Name : Undisclosed
Product Type : Vaccine
Upfront Cash : Undisclosed
March 05, 2021
Lead Product(s) : 3M-052,Potassium Alum
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Preclinical
Sponsor : IDRI
Deal Size : Undisclosed
Deal Type : Collaboration
Lead Product(s) : SCB-2019 Vaccine,SCB-2019,AS03,Potassium Alum
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Phase I
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Undisclosed
Product Name : Undisclosed
Product Type : Vaccine
Upfront Cash : Inapplicable
May 28, 2020
Lead Product(s) : SCB-2019 Vaccine,SCB-2019,AS03,Potassium Alum
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Phase I
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Potassium Alum,Inapplicable
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Phase II
Sponsor : Beijing Vigoo Biological
Deal Size : Inapplicable
Deal Type : Inapplicable
A Booster Dose of Inactivated Vaccine (Vero Cell) Against EV71 in Chinese Children
Details : Undisclosed
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Inapplicable
November 27, 2012
Lead Product(s) : Potassium Alum,Inapplicable
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Phase II
Sponsor : Beijing Vigoo Biological
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : NDV-3 Vaccine,Potassium Alum
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Phase I
Sponsor : US Department of Defense
Deal Size : Inapplicable
Deal Type : Inapplicable
Effect of Adjuvant & Route of Administration on Safety & Immunogenicity of NDV-3 Vaccine
Details : Undisclosed
Product Name : Undisclosed
Product Type : Vaccine
Upfront Cash : Inapplicable
October 06, 2011
Lead Product(s) : NDV-3 Vaccine,Potassium Alum
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Phase I
Sponsor : US Department of Defense
Deal Size : Inapplicable
Deal Type : Inapplicable